ST2 and IL-33 in Pregnancy and Pre-Eclampsia

The Immunomodulatory Role of Syncytiotrophoblast Microvesicles

(2011) Jennifer Southcombe et al.   PLoS One

Pathogenesis of Preeclampsia

(2010) Brett C. Young et al.   Annual Review of Pathology-Mechanisms of Disease

Primary sources and immunological prerequisites for sST2 secretion in humans

(2010) M. Mildner et al.   CARDIOVASCULAR RESEARCH

Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term

(2010) Karen Melchiorre et al.   HYPERTENSION

IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells

(2010) A. Yagami et al.   JOURNAL OF IMMUNOLOGY

Interleukin family member ST2 and mortality in acute dyspnoea

(2010) T. Socrates et al.   JOURNAL OF INTERNAL MEDICINE

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

(2010) Jose C Alves-Filho et al.   NATURE MEDICINE

IL-33 is a crucial amplifier of innate rather than acquired immunity

(2010) K. Oboki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

(2010) Luca Pastorelli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling

(2009) Kenjiro Seki et al.   Circulation-Heart Failure

Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases

(2009) Alexander U. Lüthi et al.   IMMUNITY

Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation

(2009) N. Houghton-Trivino et al.   JOURNAL OF GENERAL VIROLOGY

Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia—a step forward but not the definitive answer

(2009) J.M. Foidart et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells

(2009) Shinsuke Aoki et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The cytokine interleukin-33 mediates anaphylactic shock

(2009) P. N. Pushparaj et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

(2009) C. Cayrol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interleukin-33 – cytokine of dual function or novel alarmin?

(2009) Guttorm Haraldsen et al.   TRENDS IN IMMUNOLOGY

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells

(2008) M. D. Smithgall et al.   INTERNATIONAL IMMUNOLOGY

Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic Load

(2008) Jozef Bartunek et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The IL-33/ST2 pathway: therapeutic target and novel biomarker

(2008) Rahul Kakkar et al.   NATURE REVIEWS DRUG DISCOVERY

Bax, Bak and Mitochondrial Oxidants are Involved in Hypoxia-reoxygenation-induced Apoptosis in Human Placenta

(2008) T.-H. Hung et al.   PLACENTA

The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?

(2008) Christine Moussion et al.   PLoS One